Article thumbnail

α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation

By Masa-Aki Shibata, Munekazu Iinuma, Junji Morimoto, Hitomi Kurose, Kanako Akamatsu, Yasushi Okuno, Yukihiro Akao and Yoshinori Otsuki
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3121600
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1996). AJ: Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res
  2. (2007). Akao Y: Characterized mechanism of alpha-mangostin-induced cell death: caspaseindependent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg Med Chem
  3. (2010). Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development.
  4. (2002). An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12.
  5. (2009). An immunocompetent murine model of metastatic mammary cancer accessible to bioluminescence imaging. Anticancer Res
  6. (2001). Angiogenesis-dependent diseases. Semin Oncol
  7. (1996). Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus. J Pharm Pharmacol
  8. (2004). Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line.
  9. (2004). Asselin E: Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
  10. (2007). BH: PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal
  11. (2003). Braakman I: Quality control in the endoplasmic reticulum protein factory. Nature
  12. (1994). CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res
  13. (2007). Cheung PS: Spectrum of breast cancer in Asian women.
  14. (2008). Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther
  15. (2004). Conte PF: The curability of breast cancer and the treatment of advanced disease.
  16. (2004). Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Mol Cancer Res
  17. (2007). Death effector domain DEDa, a self-cleaved product of caspase-8/Mch5, translocates to the nucleus by binding to ERK1/2 and upregulates procaspase-8 expression via a p53-dependent mechanism.
  18. (2007). Easy stable transfection of a human cancer cell line by electrogene transfer with an Epstein-Barr virus-based plasmid vector. Med Mol Morphol
  19. (2007). Eng C: Breast-cancer stromal cells with TP53 mutations and nodal metastases.
  20. (1997). Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res
  21. (2007). Genetic determinants of cancer metastasis. Nat Rev Genet
  22. (2004). Genomic drug discovery for apoptosis regulation using a new computer screening amino acid complement wave method. Biol Pharm Bull
  23. Hung MC: Physiological regulation of Akt activity and stability.
  24. (2004). Inhibitory effects of crude alpha-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pac J Cancer Prev
  25. (1999). JE: Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
  26. (2004). LK: Redefining prognosis in node-negative breast cancer: can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy? Ann Surg Oncol
  27. (2004). Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis
  28. (2009). Mahabusarakam W: Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells.
  29. (2007). Mangosteen
  30. (2000). Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. Clin Cancer Res
  31. (2005). N: The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene
  32. (2004). Nozawa Y: Preferential target is mitochondria in alphamangostin-induced apoptosis in human leukemia HL60 cells. Bioorg Med Chem
  33. (2005). Nozawa Y: Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg Med Chem
  34. (2009). Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. Anticancer Res
  35. (2008). PK: Class I PI3K in oncogenic cellular transformation. Oncogene
  36. (2010). Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.
  37. (2000). RK: Angiogenesis in cancer and other diseases. Nature
  38. (2000). S: Expression of cyclooxygenase-2 in prostate carcinoma. Cancer
  39. (2007). S: Structural and functional definition of the specificity of a novel caspase-3 inhibitor,
  40. (2007). Sappino AP, Rapiti E: Recent increase of breast cancer incidence among women under the age of forty.
  41. (2002). Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Cancer Gene Ther
  42. (2009). Targeting the PI3K/AKT pathway for the treatment of prostate cancer. Clin Cancer Res
  43. (2000). The biochemistry of apoptosis. Nature
  44. (2010). The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model.
  45. (2000). The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res
  46. (2009). The National Center for Complementary and Alternative Medicine: The use of complementary and alternative medicine in the United States. Retrieve from.
  47. (1998). Tsichlis P: Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene
  48. (2004). Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Res Treat
  49. (2007). Vuori K: Novel noncatalytic role for caspase-8 in promoting SRCmediated adhesion and Erk signaling in neuroblastoma cells. Cancer Res
  50. (2000). WC: Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res
  51. (2008). WF: Recent trends in breast cancer among younger women in the United States.
  52. (2006). Y: COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer. Anticancer Res
  53. (2007). Y: Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation. Cancer Chemother Pharmacol
  54. (2009). YW: Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway. J Agric Food Chem
  55. (2010). YW: alpha-Mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells.